A proof-of-principle phase II study investigated whether the addition of pro-immunogenic granulocyte-macrophage colony-stimulating factor (GM-CSF) through dendritic cell maturation could reproducibly induce immunity-mediated tumor response outside the radiation field [26]. The gene discussed is CSF2; the disease is neoplasm.